SAGE meeting of 6 - 8 April 2009
Background documents
Session: Report from IVB Director
-
Meeting of the immunization Strategic Advisory Group of Experts (SAGE), November 2008 – conclusions and recommendations
pdf, 286kb -
Current SAGE working groups
pdf, 52kb -
SAGE tracking sheet
pdf, 115kb
Session: Priorities, major policy and implementation issues: reports from AFRO, EMRO, and SEARO
-
AFR: WHO AFRO - IVD programme: 2008 TFI recommendations
pdf, 31kb -
EMR: Conclusion and recommendations of the 23rd meeting of the EPI regional technical advisory group, 21-23 October 2008, Alexandria Egypt
pdf, 27kb -
SEAR: Report of the first South-East Asia Regional Technical Advisory Group on Immunization (SEAR ITAG) meeting, 14-15 July 2008, Bangkok, Thailand
pdf, 99kb
Session: Polio
-
Conclusions and recommendations of the Advisory Committee on Poliomyelitis Eradication, November 2008
pdf, 231kb -
Draft Global Polio Eradication Initiative, 62nd World Health Assembly, May 2009
pdf, 587kb
At the time of the SAGE meeting, only a draft of this document was available:
Session: Influenza
Session: Reports from other Advisory Committees in Immunization
-
Global Advisory Committee on Vaccine Safety, 17-18 December 2008
pdf, 171kb -
Summary of WHO Quantitative Immunization and Vaccines Related Research (QUIVER) Advisory Committee activities 2008
pdf, 31kb -
Report on the WHO Quantative Immunization and Vaccines Related Research (QUIVER) advisory committee meeting, Geneva, 21-22 October 2008
pdf, 270kb - WHO guide for standardization of economic evaluations of immunization programmes [pdf 1.34Mb]
Session: Report from the GAVI secretariat
Session: Hepatitis B vaccine (A recent systematic review was conducted as part of a Cochrane Review by Lee et al (Lee C, Gong Y, Brok J, Boxall EH, Gluud C. Hepatitis B immunisation for newborn infants of hepatitis B surface antigen-positive mothers.)
-
Grade table 1: Should hepatitis B vaccine at birth be used for prevention of hepatitis B virus infection in newborns?
pdf, 36kb -
Grade table 2: Should hepatitis B vaccine within 7 days following birth be used for the prevention of infection in infants?
pdf, 34kb -
Grade table 3: Should hepatitis B immunoglobulin at birth versus placebo or no intervention be used for the prevention of hepatitis B virus infection?
pdf, 27kb -
Grade table 4: Should primary hepatitis B series be used for long-term protection against hepatitis B virus infection?
pdf, 35kb -
Hepatitis B immunisation for newborn infants of hepatitis B surface antigen-positive mothers (Review)
pdf, 573kb
Session: Report from stakeholders' panel
-
A stakeholders' panel to evaluate the impact of "strengthening WHO's normative and policy setting functions for immunization, 2006-2010". Mid.term evaluation, report March 2009
pdf, 1.23Mb -
Impact of WHO normative and policy guidance on vaccines and immunization - summary of survey report
pdf, 27kb
Session: Measles
-
Report on the 1st meeting of the SAGE working group on measles, 28 September 2006
pdf, 367kb -
Conclusions and recommendations of the Strategic Advisory Group of Experts (SAGE) from the meeting of November 2006
pdf, 330kb -
Conclusions and proceedings from the 2nd meeting of the SAGE working group on measles, 8-10 September 2008
pdf, 384kb -
Draft conclusions of the 3rd meeting of the SAGE working group on measles, 29-30 January 2009, Geneva
pdf, 266kb -
Economic analysis of measles eradication
pdf, 41kb -
Assessment of the impact of measles eradication activities on routine immunization and on health systems
pdf, 92kb -
Progress in global measles control and mortality reduction, 2000–2007
pdf, 310kb -
Estimates of measles case fatality ratios: a comprehensive review of community-based studies
pdf, 163kb
Presentations from 3rd measles WG meeting
-
Report on the November 2008 SAGE discussion on measles and expected outcomes
pdf, 294kb -
Field effectiveness of measles containing vaccines - literature review
pdf, 133kb -
Measles Elimination in the Americas: A Comparison of Countries With a One-dose and Two-dose Routine Measles Vaccination Schedule
pdf, 425kb -
Measles incidence and immunization
pdf, 36kb -
Decision analysis to guide policy on the introduction of a routine second dose of measles vaccine
pdf, 676kb -
Decision Analysis to Guide Policy on the Introduction of a Routine Second Dose of Measles Vaccine
pdf, 1.04Mb -
Measles Strategic Planning Tool: Analysis of MCV strategies in developing countries
pdf, 328kb -
What is the optimal age to give MCV2? - Recommendations on timing
pdf, 331kb -
Assessing the feasibility of global measles elimination
pdf, 347kb